Boston Massachusetts based TScan Therapeutics is raising $23,300,000.00 in a new round of Venture Capital investment.
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, TScan Therapeutics is raising $23,300,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, David…